Home › Funds › Evelyn Partners Group Ltd › JNJ

Evelyn Partners Group Ltd position in JNJ

JOHNSON & JOHNSON · Health Care

Evelyn Partners Group Ltd reported holding 303,769 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$80.4M, representing 1.29% of its reported portfolio and ranking #18 among its reported holdings. Evelyn Partners Group Ltd has disclosed JNJ holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)303.77K sh
Reported value held$80.42M
Portfolio Weight1.29%
First reportedQ2 2026
Last changeAdd
Updated2026-11-10

Last updated: 2026-11-10 · Source: SEC EDGAR Form 13F-HR

How Evelyn Partners Group Ltd's JNJ position evolved

Evelyn Partners Group Ltd first disclosed a stake in JNJ in Q2 2026 at 297,561 shares (US$75.6M). The position peaked in Q3 2026 at 303,769 shares, worth US$80.4M. Across 2 filings, Evelyn Partners Group Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 303,769 shares valued at US$80.4M — an increase of 6,208 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 297.56K $75.57M New
Q3 2026 303.77K $80.42M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Evelyn Partners Group Ltd held JNJ?

Evelyn Partners Group Ltd has disclosed JNJ holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Evelyn Partners Group Ltd's current position in JNJ?

As of Q3 2026, Evelyn Partners Group Ltd holds 303.77K shares of JNJ (JOHNSON & JOHNSON), valued at $80.42M, representing 1.29% of its reported portfolio and ranking #18.

Has Evelyn Partners Group Ltd been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Evelyn Partners Group Ltd increased its position in JNJ. The position peaked in Q3 2026 at 303.77K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.